PHENOXYBENZAMINE HYDROCHLORIDE

PHENOXYBENZAMINE HYDROCHLORIDE was reported 27 times

These side effects are most commonly reported by patients taking PHENOXYBENZAMINE HYDROCHLORIDE:

# Side effect Count
0 URINARY TRACT INFECTION 6
1 COVID-19 4
2 BLOOD PRESSURE DECREASED 3
3 DIARRHOEA 3
4 DIZZINESS 3
5 HEADACHE 3
6 INFLUENZA 3
7 CATASTROPHIC REACTION 2
8 CONSTIPATION 2
9 CYSTITIS 2
10 DEHYDRATION 2
11 DELIRIUM 2
12 DEVICE USE ISSUE 2
13 FATIGUE 2
14 FEEDING DISORDER 2
15 HALLUCINATION 2
16 HYPERKINESIA 2
17 HYPERTENSION 2
18 INFUSION SITE INDURATION 2
19 INFUSION SITE MASS 2
20 MOBILITY DECREASED 2
21 MUSCLE SPASMS 2
22 MUSCULOSKELETAL STIFFNESS 2
23 ON AND OFF PHENOMENON 2
24 PATIENT-DEVICE INCOMPATIBILITY 2
25 PNEUMONIA 2
26 RESTLESSNESS 2
27 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
28 VISUAL IMPAIRMENT 2
29 WEIGHT DECREASED 2
30 ABDOMINAL PAIN 1
31 ACUTE MYOCARDIAL INFARCTION 1
32 ADRENERGIC SYNDROME 1
33 AGITATION 1
34 ALOPECIA 1
35 ALOPECIA AREATA 1
36 ANAEMIA 1
37 ANGINA PECTORIS 1
38 ATRIAL TACHYCARDIA 1
39 AZOTAEMIA 1
40 BLOOD LACTIC ACID INCREASED 1
41 BLOOD LOSS ANAEMIA 1
42 BLOOD PH DECREASED 1
43 BLOOD PRESSURE DIASTOLIC INCREASED 1
44 BLOOD PRESSURE SYSTOLIC DECREASED 1
45 BLOOD PRESSURE SYSTOLIC INCREASED 1
46 BRADYCARDIA 1
47 BRADYCARDIA FOETAL 1
48 BREAST ABSCESS 1
49 CAESAREAN SECTION 1
50 CALCINOSIS 1
51 CARCINOID CRISIS 1
52 CARDIAC ARREST 1
53 CARDIOGENIC SHOCK 1
54 CIRCULATORY COLLAPSE 1
55 CONFUSIONAL STATE 1
56 CORONARY ARTERY DISEASE 1
57 DECREASED APPETITE 1
58 DEPRESSED LEVEL OF CONSCIOUSNESS 1
59 DEPRESSION 1
60 DIALYSIS 1
61 DISORIENTATION 1
62 DRUG INTERACTION 1
63 DRUG WITHDRAWAL SYNDROME 1
64 DYSURIA 1
65 ELECTROCARDIOGRAM QT PROLONGED 1
66 EPIDIDYMITIS 1
67 EPISTAXIS 1
68 FALL 1
69 FLUSHING 1
70 FOETAL EXPOSURE DURING PREGNANCY 1
71 HAEMATOCRIT DECREASED 1
72 HAEMODYNAMIC INSTABILITY 1
73 HAEMOGLOBIN DECREASED 1
74 HAEMORRHOIDAL HAEMORRHAGE 1
75 HALLUCINATION, VISUAL 1
76 HEART RATE INCREASED 1
77 HEPATIC ENZYME INCREASED 1
78 HIDRADENITIS 1
79 HYPOPERFUSION 1
80 HYPOPNOEA 1
81 HYPOTHYROIDISM 1
82 INSOMNIA 1
83 INTENTIONAL UNDERDOSE 1
84 ISCHAEMIA 1
85 LACTIC ACIDOSIS 1
86 LOSS OF CONSCIOUSNESS 1
87 LYMPHADENOPATHY 1
88 MALIGNANT NEOPLASM PROGRESSION 1
89 MATERNAL DRUGS AFFECTING FOETUS 1
90 MEMORY IMPAIRMENT 1
91 MENTAL IMPAIRMENT 1
92 MENTAL STATUS CHANGES 1
93 METASTASES TO LIVER 1
94 MICROCYTIC ANAEMIA 1
95 MICTURITION DISORDER 1
96 MULTIPLE SCLEROSIS RELAPSE 1
97 NAUSEA 1
98 NERVE INJURY 1
99 OFF LABEL USE 1
100 ORCHITIS 1
101 OROPHARYNGEAL PAIN 1
102 OXYGEN SATURATION DECREASED 1
103 PALPITATIONS 1
104 PARAGANGLION NEOPLASM 1
105 POLYNEUROPATHY 1
106 PREMATURE BABY 1
107 PRODUCT ADMINISTRATION ERROR 1
108 PRODUCT AVAILABILITY ISSUE 1
109 PROTEIN TOTAL DECREASED 1
110 PSEUDODEMENTIA 1
111 RIGHT VENTRICULAR DYSFUNCTION 1
112 SOMNOLENCE 1
113 SUPRAVENTRICULAR TACHYCARDIA 1
114 SYNCOPE 1
115 THERAPEUTIC AGENT-DIAGNOSTIC TEST INTERACTION 1
116 THERAPEUTIC RESPONSE DECREASED 1
117 TRICUSPID VALVE INCOMPETENCE 1
118 TUMOUR RUPTURE 1
119 VAGINAL CANCER 1
120 VASOPLEGIA SYNDROME 1
121 VISION BLURRED 1
122 VITREOUS HAEMORRHAGE 1
123 VOMITING 1